Literature DB >> 1993123

Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation.

T L Wimpey1, C Chavkin.   

Abstract

Opioid receptors were found to activate two different types of membrane potassium conductance in acutely dissociated neurons from the CA1/subiculum regions of the adult rat hippocampal formation. Opioid-responsive neurons were distinguished based on their morphology and electrophysiological responses. In one population of neurons having a multipolar, nonpyramidal cell shape, mu-selective opioid agonists increased an inward rectifying potassium current. Opioid activation of the inward rectifying conductance resulted in small outward potassium currents at resting membrane potentials and increased inward currents at hyperpolarized potentials. In a second population of nonpyramidal neurons, mu opioid agonists increased a novel voltage-gated potassium current. This current was blocked by internal CsCl2, unaffected by external BaCl2 or CdCl2, irreversibly activated by intracellular GTP-gamma-S, and inactivated by sustained depolarization. In contrast to the inward rectifying conductance, the voltage-gated conductance was not activated at resting membrane potentials or hyperpolarized potentials. The opioid-activated, voltage-gated conductance represents a new class of G protein-regulated potassium current in the brain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993123     DOI: 10.1016/0896-6273(91)90363-5

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  39 in total

1.  G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons.

Authors:  Maria Torrecilla; Cheryl L Marker; Stephanie C Cintora; Markus Stoffel; John T Williams; Kevin Wickman
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

2.  Morphine- and CaMKII-dependent enhancement of GIRK channel signaling in hippocampal neurons.

Authors:  Rounak Nassirpour; Laia Bahima; Arnaud L Lalive; Christian Lüscher; Rafael Luján; Paul A Slesinger
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

3.  Changes in accumbal and pallidal pCREB and deltaFosB in morphine-sensitized rats: correlations with receptor-evoked electrophysiological measures in the ventral pallidum.

Authors:  John McDaid; Jeanine E Dallimore; Alexander R Mackie; T Celeste Napier
Journal:  Neuropsychopharmacology       Date:  2006-06       Impact factor: 7.853

4.  Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists.

Authors:  P A Claude; D R Wotta; X H Zhang; P L Prather; T M McGinn; L J Erickson; H H Loh; P Y Law
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  Cortical opioid markers in schizophrenia and across postnatal development.

Authors:  David W Volk; Polina V Radchenkova; Erin M Walker; Elizabeth J Sengupta; David A Lewis
Journal:  Cereb Cortex       Date:  2011-08-01       Impact factor: 5.357

6.  Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents.

Authors:  K R Svoboda; C R Lupica
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

7.  Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons.

Authors:  K R Svoboda; C E Adams; C R Lupica
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

8.  Increased probability of GABA release during withdrawal from morphine.

Authors:  A Bonci; J T Williams
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

9.  Mechanism of mu-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro.

Authors:  M Capogna; B H Gähwiler; S M Thompson
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

10.  Alterations in brain metabolism induced by chronic morphine treatment: NMR studies in rat CNS.

Authors:  Sushil K Sharma; Kiran Yashpal; Marian E Fundytus; Françoise Sauriol; James L Henry; Terence J Coderre
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.